Skip to Content

Adenosine Injection

Last Updated: May 26, 2016
Status: Resolved

Products Affected - Description
    • Adenosine intravenous injection, West-Ward, 3 mg/mL, 2 mL vial, 10 count, NDC 00641-6113-10
Reason for the Shortage
    • Astellas discontinued Adenoscan in April 2015. Adenoscan is used for diagnostic purposes as an adjunct to thallium-201 myocardial perfusion scintigraphy. Adenocard and generic adenosine products are labeled for use in paroxysmal supraventricular tachycardia.
    • Sagent had adenosine vials on shortage due to increased demand.
    • West-Ward has adenosine injection on shortage due to manufacturing delays.
Available Products
    • Adenosine intravenous injection, Akorn, 3 mg/mL, 20 mL vial, 1 count, NDC 17478-0544-20
    • Adenosine intravenous injection, Akorn, 3 mg/mL, 30 mL vial, 1 count, NDC 17478-0544-30
    • Adenosine intravenous injection, Pfizer, 3 mg/mL, 20 mL vial, 25 count, NDC 00409-1932-01
    • Adenosine intravenous injection, Pfizer, 3 mg/mL, 30 mL vial, 25 count, NDC 00409-1932-02
    • Adenosine intravenous injection, Sagent, 3 mg/mL, 20 mL vial, 1 count, NDC 25021-0307-20
    • Adenosine intravenous injection, Sagent, 3 mg/mL, 30 mL vial, 1 count, NDC 25021-0307-30
    • Adenosine intravenous injection, Teva, 3 mg/mL, 20 mL vial, 1 count, NDC 00703-8776-01
    • Adenosine intravenous injection, Teva, 3 mg/mL, 30 mL vial, 1 count, NDC 00703-8777-01
    • Adenocard intravenous injection, Astellas, 3 mg/mL, 2 mL prefilled syringe, 10 count, NDC 00469-8234-12
    • Adenocard intravenous injection, Astellas, 3 mg/mL, 4 mL prefilled syringe, 10 count, NDC 00469-8234-14
    • Adenosine intravenous injection, Akorn, 3 mg/mL, 2 mL vial, 10 count, NDC 17478-0542-02
    • Adenosine intravenous injection, Akorn, 3 mg/mL, 2 mL vial, 25 count, NDC 17478-0542-25
    • Adenosine intravenous injection, Fresenius Kabi, 3 mg/mL, 2 mL vial, 10 count, NDC 63323-0651-02
    • Adenosine intravenous injection, Fresenius Kabi, 3 mg/mL, 4 mL vial, 10 count, NDC 63323-0651-04
    • Adenosine intravenous injection, Sagent, 3 mg/mL, 2 mL prefilled syringe, 10 count, NDC 25021-0301-67
    • Adenosine intravenous injection, Sagent, 3 mg/mL, 2 mL vial, 10 count, NDC 25021-0301-02
    • Adenosine intravenous injection, Sagent, 3 mg/mL, 4 mL prefilled syringe, 10 count, NDC 25021-0301-68
    • Adenosine intravenous injection, Sagent, 3 mg/mL, 4 mL vial, 10 count, NDC 25021-0301-04

Estimated Resupply Dates

    • West-Ward has adenosine 3 mg/mL 2 mL vials on back order and the company cannot estimate a release date.
    • All other marketed presentations are available.

Updated

Updated May 26, 2016 by Leslie Jensen, PharmD, Drug Information Specialist. Created November 19, 2012 by Michelle Wheeler, PharmD, Drug Information Specialist. Copyright 2017, Drug Information Service, University of Utah, Salt Lake City, UT.

Hide